BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33992679)

  • 1. Effect of different sample treatment methods on Low Endotoxin Recovery Phenomenon.
    Bu R; Deng X; Cao Y; Jin J; Mai B; Meng K; Liu X; Chi JC; Zhang Y; Qiu F
    J Microbiol Methods; 2021 Jul; 186():106241. PubMed ID: 33992679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon.
    Correa W; Brandenburg K; Zähringer U; Ravuri K; Khan T; von Wintzingerode F
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems.
    Reich J; Lang P; Grallert H; Motschmann H
    Biologicals; 2016 Sep; 44(5):417-22. PubMed ID: 27464990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low endotoxin recovery and its impact on endotoxin detection.
    Cao Y; Zhang Y; Qiu F
    Biopolymers; 2021 Nov; 112(11):e23470. PubMed ID: 34407207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the kinetics and mechanism of low endotoxin recovery in a matrix for biopharmaceutical drug products.
    Reich J; Tamura H; Nagaoka I; Motschmann H
    Biologicals; 2018 May; 53():1-9. PubMed ID: 29685804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample Treatments That Solve Low Endotoxin Recovery Issues.
    Tsuchiya M
    PDA J Pharm Sci Technol; 2019; 73(5):433-442. PubMed ID: 30902837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery.
    Gorman A; Golovanov AP
    Eur J Pharm Biopharm; 2022 Nov; 180():289-307. PubMed ID: 36272656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay.
    Schromm AB; Correa W; Gisch N; Steiniger F; Richter W; Martinez-de-Tejada G; Brandenburg K; von Wintzingerode F
    Biomed Pharmacother; 2024 Apr; 173():116286. PubMed ID: 38401515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Endotoxin Recovery-Masking of Naturally Occurring Endotoxin.
    Reich J; Weyer FA; Tamura H; Nagaoka I; Motschmann H
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study.
    Bolden J; Knight M; Montz J; One J; Stockman S; Jones SP
    Biologicals; 2024 Jun; 87():101779. PubMed ID: 38908364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays.
    Neun BW; Dobrovolskaia MA
    Methods Mol Biol; 2011; 697():121-30. PubMed ID: 21116960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin recovery using limulus amebocyte lysate (LAL) assay.
    Bolden JS; Warburton RE; Phelan R; Murphy M; Smith KR; De Felippis MR; Chen D
    Biologicals; 2016 Sep; 44(5):434-40. PubMed ID: 27470947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin detection--from limulus amebocyte lysate to recombinant factor C.
    Ding JL; Ho B
    Subcell Biochem; 2010; 53():187-208. PubMed ID: 20593268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects.
    Gnauck A; Lentle RG; Kruger MC
    J Immunol Methods; 2015 Jan; 416():146-56. PubMed ID: 25433222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How pH, Temperature, and Time of Incubation Affect False-Positive Responses and Uncertainty of the LAL Gel-Clot Test.
    Lourenço FR; Botelho Tde S; Pinto Tde J
    PDA J Pharm Sci Technol; 2012; 66(6):542-6. PubMed ID: 23183650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Validation Study of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Polyvalent Horse Snake Antivenom.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2019; 73(6):562-571. PubMed ID: 30770487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential blocking of coagulation-activating pathways of Limulus amebocyte lysate.
    Zhang GH; Baek L; Buchardt O; Koch C
    J Clin Microbiol; 1994 Jun; 32(6):1537-41. PubMed ID: 8077400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Activity of Masked Endotoxin.
    Schwarz H; Gornicec J; Neuper T; Parigiani MA; Wallner M; Duschl A; Horejs-Hoeck J
    Sci Rep; 2017 Mar; 7():44750. PubMed ID: 28317862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New microassay for quantitation of endotoxin using Limulus amebocyte lysate combined with enzyme-linked immunosorbent assay.
    Zhang GH; Baek L; Koch C
    J Clin Microbiol; 1988 Aug; 26(8):1464-70. PubMed ID: 3170710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human endothelial cell-based assay for endotoxin as sensitive as the conventional Limulus Amebocyte Lysate assay.
    Unger RE; Peters K; Sartoris A; Freese C; Kirkpatrick CJ
    Biomaterials; 2014 Mar; 35(10):3180-7. PubMed ID: 24456607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.